Literature DB >> 21805041

Expression of P-gp, MRP, LRP, GST-π and TopoIIα and intrinsic resistance in human lung cancer cell lines.

Jiarui Wang1, Jinhui Zhang, Lichuan Zhang, Long Zhao, Sufang Fan, Zhonghai Yang, Fei Gao, Ying Kong, Gary Guishan Xiao, Qi Wang.   

Abstract

This study aimed to determine the relationship between the endogenous levels of P-glycoprotein (P-gp), multidrug resistance-associated protein (MRP), lung resistance-related protein (LRP), glutathione-s-transferase-π (GST‑π) and topoisomerase IIα (TopoIIα) and intrinsic drug resistance in four human lung cancer cell lines, SK-MES-1, SPCA-1, NCI-H-460 and NCI-H-446, of different histological types. The expression of P-gp, MRP, LRP, GST-π and TopoIIα was measured by immunofluorescence, Western blotting and RT-PCR. Drug resistance to cisplatin, doxorubicin and VP-16 was determined using MTT assays. The correlation between expression of the resistance-related proteins and their roles in the resistance to drugs in these cancer cell lines was analyzed. We found that the endogenous levels of P-gp, MRP, LRP, GST-π and TopoIIα in the four cell lines varied. The level of GST-π in the SK-MES-1 cells was the highest, whereas the level of P-gp in the SPCA-1 cells was the lowest. The chemoresistance to cisplatin, doxorubicin and VP-16 in the four cell lines was different. The SPCA-1 cell line was most resistance to cisplatin; SK-MES-1 was most resistance to VP-16; whereas SK-MES-1 was most sensitive to doxorubicin. There was a positive correlation between GST-π expression and resistance to cisplatin, between TopoIIα expression and resistance to VP-16; and a negative correlation was noted between TopoIIα expression and resistance to doxorubicin. In summary, the endogenous expression of P-gp, MRP, LRP, GST-π and TopoIIα was different in the four human lung cancer cell lines of different histological types, and this variance may be associated with the variation in chemosensitivity to cisplatin, doxorubicin and VP-16. Among the related proteins, GST-π may be useful for the prediction of the intrinsic resistance to cisplatin, whereas TopoIIα may be useful to predict resistance to doxorubicin and VP-16 in human lung cancer cell lines.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21805041     DOI: 10.3892/or.2011.1405

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  22 in total

Review 1.  miRNAs as Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer: Current Perspectives.

Authors:  Mateusz Florczuk; Adam Szpechcinski; Joanna Chorostowska-Wynimko
Journal:  Target Oncol       Date:  2017-04       Impact factor: 4.493

2.  MEK inhibitor enhances sensitivity to chemotherapeutic drugs in multidrug resistant hepatocellular carcinoma cells.

Authors:  Qingliang Meng; Xiaoqi He; Guangwei Xie; Qingzhong Tian; Xiaogang Shu; Jin Li; Yong Xiao
Journal:  Oncol Lett       Date:  2017-06-30       Impact factor: 2.967

3.  Binding and inhibition of drug transport proteins by heparin: a potential drug transporter modulator capable of reducing multidrug resistance in human cancer cells.

Authors:  Yunliang Chen; Michael Scully; Gloria Petralia; Ajay Kakkar
Journal:  Cancer Biol Ther       Date:  2013-11-19       Impact factor: 4.742

4.  Systematic expression analysis of genes related to multidrug-resistance in isogenic docetaxel- and adriamycin-resistant breast cancer cell lines.

Authors:  Wen-Jing Li; Shan-Liang Zhong; Yuan-Jian Wu; Wei-Dong Xu; Jin-Jin Xu; Jin-Hai Tang; Jian-Hua Zhao
Journal:  Mol Biol Rep       Date:  2013-11       Impact factor: 2.316

5.  Multidrug resistance protein and topoisomerase 2 alpha expression in non-small cell lung cancer are related with brain metastasis postoperatively.

Authors:  Huan Huang; Jihong Liu; Qinglian Meng; Guozhong Niu
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

6.  Expression of multidrug-resistance associated proteins in human retinoblastoma treated by primary enucleation.

Authors:  Li-Juan Tang; Li-Jun Zhou; Wen-Xin Zhang; Jian-Yan Lin; Yong-Ping Li; Hua-Sheng Yang; Ping Zhang
Journal:  Int J Ophthalmol       Date:  2018-09-18       Impact factor: 1.779

7.  Cancer Associated Fibroblast-Derived Hepatocyte Growth Factor Inhibits the Paclitaxel-Induced Apoptosis of Lung Cancer A549 Cells by Up-Regulating the PI3K/Akt and GRP78 Signaling on a Microfluidic Platform.

Authors:  Li Ying; Ziwei Zhu; Zhiyun Xu; Tianrui He; Encheng Li; Zhe Guo; Fen Liu; Chunmeng Jiang; Qi Wang
Journal:  PLoS One       Date:  2015-06-26       Impact factor: 3.240

8.  Expression and significance of glucose transporter-1, P-glycoprotein, multidrug resistance-associated protein and glutathione S-transferase-π in laryngeal carcinoma.

Authors:  Zhong-Ping Mao; Li-Jun Zhao; Shui-Hong Zhou; Meng-Qin Liu; Wei-Feng Tan; Hong-Tian Yao
Journal:  Oncol Lett       Date:  2014-12-01       Impact factor: 2.967

9.  8-Methoxypsoralen is a competitive inhibitor of glutathione S-transferase P1-1.

Authors:  Diêgo Madureira de Oliveira; Marcel Tavares de Farias; André Lacerda Braga Teles; Manoelito Coelho Dos Santos Junior; Martins Dias de Cerqueira; Rute Maria Ferreira Lima; Ramon Santos El-Bachá
Journal:  Front Cell Neurosci       Date:  2014-09-30       Impact factor: 5.505

10.  Glutathione S-Transferase Gene Polymorphisms and Treatment Outcome in Cervical Cancer Patients under Concomitant Chemoradiation.

Authors:  Mohammad Abbas; Vandana Singh Kushwaha; Kirti Srivastava; Monisha Banerjee
Journal:  PLoS One       Date:  2015-11-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.